A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
Dr Roger J. Young, Professor at Saba University School of Medicine, walks us through Brittle Bone Disease, otherwise known as Osteogenesis Imperfecta Type I.
Advancing neuroscience research improves quality of life for all people with neurological disorders, and ultimately can prevent or cure these diseases. Open Access Government highlight some research priorities in neuroscience.
Jacqueline Hoogendam, JPND’s newly elected Vice-Chair and Executive Board member talks about JPND’s past and present strategies in its outreach campaign within and beyond Europe.
It is now well-known that the virus can create severe respiratory issues - but the impact of COVID on the brain is an equally important, unanswered question.
Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.
Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.
A new study finds the exact molecular mechanism that turns acute pain into chronic pain - a condition that leads to the use of opioids and often, lifelong addiction.
The study, published in PLoS Biology, looked at the neurotransmitter in the brain that calculates whether to pursue a task - in other words, motivation.
